Xtx Topco LTD Kinnate Biopharma Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.24 - $2.66 $96,255 - $114,302	42,971 Added 69.91%	104,437 $277,000
Q4 2023 Feb 13, 2024	BUY	$1.07 - $2.5 $13,485 - $31,507	12,603 Added 25.79%	61,466 $145,000
Q3 2023 Nov 13, 2023	SELL	$1.38 - $3.31 $32,343 - $77,576	-23,437 Reduced 32.42%	48,863 $68,000
Q2 2023 Aug 14, 2023	BUY	$2.33 - $6.84 $168,459 - $494,532	72,300 New	72,300 $219,000
Q4 2022 Feb 14, 2023	BUY	$5.26 - $12.19 $204,035 - $472,850	38,790 New	38,790 $236,000

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.